These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. A comparative review of classification systems in myelodysplastic syndromes (MDS). Bennett JM Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011 [TBL] [Abstract][Full Text] [Related]
13. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes. Komrokji RS; Bennett JM Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868 [TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of myelodysplastic syndrome. Nivatpumin PJ; Gore SD Expert Opin Emerg Drugs; 2005 Aug; 10(3):569-90. PubMed ID: 16083330 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study. Vey N; Bosly A; Guerci A; Feremans W; Dombret H; Dreyfus F; Bowen D; Burnett A; Dennis M; Ribrag V; Casadevall N; Legros L; Fenaux P J Clin Oncol; 2006 Jun; 24(16):2465-71. PubMed ID: 16651646 [TBL] [Abstract][Full Text] [Related]
16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review. Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676 [TBL] [Abstract][Full Text] [Related]
17. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications. Panani AD; Roussos C Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553 [TBL] [Abstract][Full Text] [Related]
18. The evolution of hematopoietic SCT in myelodysplastic syndrome. Kindwall-Keller T; Isola LM Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532 [TBL] [Abstract][Full Text] [Related]
19. Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes. Schiller GJ; Slack J; Hainsworth JD; Mason J; Saleh M; Rizzieri D; Douer D; List AF J Clin Oncol; 2006 Jun; 24(16):2456-64. PubMed ID: 16651647 [TBL] [Abstract][Full Text] [Related]
20. Update on the therapy for myelodysplastic syndrome. Kasner MT; Luger SM Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]